Mortality rate from Candida infections remains high in Brazil, despite therapeutic advances

An article published in the Journal of Fungi analyzing bloodstream infection by fungi of the genus Candida, and comparing data for the periods 2010–11 and 2017–18 in Brazil, shows the persistence of extremely high mortality rates despite advances in therapeutic practices. Candidemia is the world’s most prevalent nosocomial (hospital-acquired) invasive fungal infection. Its incidence varies globally from 0.33 to 6.51 episodes per 1,000 admissions.